Shanghai Kaibao Pharmaceutical (300039) — Cash Flow Quality Index
Shanghai Kaibao Pharmaceutical (300039) has a Cash Flow Quality Index of 2.93x as of September 2025. Operating cash flow of CN¥190.98 Million exceeds net income of CN¥65.09 Million, indicating high earnings quality where cash backs reported profits. Explore 300039 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Kaibao Pharmaceutical Cash Flow Quality Index (2006–2024)
Historical Cash Flow Quality Index for Shanghai Kaibao Pharmaceutical across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shanghai Kaibao Pharmaceutical (300039) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Kaibao Pharmaceutical (2006–2024)
Year-by-year earnings quality comparison for Shanghai Kaibao Pharmaceutical. For live market cap and the full company financial profile, see market cap of Shanghai Kaibao Pharmaceutical.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | CN¥278.95 Million | CN¥374.91 Million | ▼ -36.2% |
| 2023 | 1.17x | CN¥382.66 Million | CN¥327.87 Million | ▼ -41.1% |
| 2022 | 1.98x | CN¥376.42 Million | CN¥190.08 Million | ▲ +120.1% |
| 2021 | 0.90x | CN¥126.08 Million | CN¥140.11 Million | ▼ -61.9% |
| 2020 | 2.36x | CN¥250.65 Million | CN¥106.12 Million | ▲ +77.4% |
| 2019 | 1.33x | CN¥334.09 Million | CN¥250.99 Million | ▲ +15.1% |
| 2018 | 1.16x | CN¥262.36 Million | CN¥226.81 Million | ▲ +28.2% |
| 2017 | 0.90x | CN¥245.76 Million | CN¥272.30 Million | ▼ -19.0% |
| 2016 | 1.11x | CN¥314.88 Million | CN¥282.61 Million | ▼ -4.1% |
| 2015 | 1.16x | CN¥327.08 Million | CN¥281.65 Million | ▲ +43.7% |
| 2014 | 0.81x | CN¥282.38 Million | CN¥349.35 Million | ▼ -4.6% |
| 2013 | 0.85x | CN¥270.23 Million | CN¥318.82 Million | ▼ -15.6% |
| 2012 | 1.00x | CN¥243.32 Million | CN¥242.19 Million | ▲ +71.2% |
| 2011 | 0.59x | CN¥98.31 Million | CN¥167.56 Million | ▲ +266.8% |
| 2010 | 0.16x | CN¥19.79 Million | CN¥123.70 Million | ▼ -79.2% |
| 2009 | 0.77x | CN¥52.74 Million | CN¥68.67 Million | ▲ +136.8% |
| 2008 | 0.32x | CN¥18.70 Million | CN¥57.65 Million | ▼ -37.6% |
| 2007 | 0.52x | CN¥23.27 Million | CN¥44.81 Million | ▼ -45.0% |
| 2006 | 0.94x | CN¥19.70 Million | CN¥20.87 Million | — |